Urologix, Inc.
ULGX
$0.0001
$0.000.00%
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Net Income | 2.24% | 18.31% | 87.60% | -111.84% | -53.36% |
| Total Depreciation and Amortization | -4.31% | -13.43% | -4.29% | -3.45% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.64% | -9.58% | -94.73% | 263.30% | 565.65% |
| Change in Net Operating Assets | -50.82% | 458.82% | -126.98% | -36.36% | -64.20% |
| Cash from Operations | -206.25% | 118.82% | -86.81% | 79.73% | -75.39% |
| Capital Expenditure | -- | 100.00% | 75.00% | -300.00% | 96.00% |
| Sale of Property, Plant, and Equipment | -20.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.08% | -2,500.00% | 33.33% | -200.00% | 66.67% |
| Cash from Investing | 91.49% | -1,466.67% | 57.14% | -250.00% | 92.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -153.33% | 91.33% | -76.53% | 78.27% | -58.80% |
